Efficacy of novel β
3
‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study
2018 ◽
Vol 26
(3)
◽
pp. 369-375
◽
Keyword(s):
Phase 3
◽